Activation of human RNase L by 5’-C-phosphonate-modified oligoadenylates

Author(s):  
Magdalena Petrová ◽  
Miloš Buděšínský ◽  
Eva Zborníková ◽  
Natalia Panova ◽  
Pavel Novák ◽  
...  
Keyword(s):  
Rnase L ◽  
Coronaviruses ◽  
2021 ◽  
Vol 02 ◽  
Author(s):  
Chellapandi P ◽  
Saranya S

: Coronavirus disease (COVID-19) pandemic is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), a new coronavirus isolated from Wuhan, China. It is a global health emergency, and there is no effective antiviral therapeutics available to date. Continuous structural genomic insights of SARS-CoV-2 proteins provide a warranty for the development of rational-based antivirals. Nevertheless, a structure-based drug candidate with multiple therapeutic actions would be a practical choice of medication in the treatment of severe COVID-19 patients. Cordycepin from medicinal fungi (Cordyceps spp.) and its nucleoside analogs targeting viral RNA-dependent RNA polymerase and human RNase L have potent antiviral activity against various human viruses with additional immunomodulatory and anti-inflammatory effects. Anti-inflammation treatment is of pivotal importance and should be timely tailored to the individual patient along with antivirals. Our perspective on the combined antiviral and anti-inflammatory effects of cordycepin and its analogs suggests them as new therapeutics in the treatment of systemic COVID-19 infection.


2003 ◽  
Vol 3 (1) ◽  
pp. 63-64 ◽  
Author(s):  
Y. Ueno ◽  
S. Okatani ◽  
Y. Yamada ◽  
Y. Kitade
Keyword(s):  
Rnase L ◽  

2017 ◽  
Vol 91 (14) ◽  
Author(s):  
Melissa Drappier ◽  
Fred R. Opperdoes ◽  
Thomas Michiels

ABSTRACT Vilyuisk human encephalitis virus (VHEV) is a picornavirus related to Theiler's murine encephalomyelitis virus (TMEV). VHEV was isolated from human material passaged in mice. Whether this VHEV is of human or mouse origin is therefore unclear. We took advantage of the species-specific activity of the nonstructural L* protein of theiloviruses to track the origin of TMEV isolates. TMEV L* inhibits RNase L, the effector enzyme of the interferon pathway. By using coimmunoprecipitation and functional RNase L assays, the species specificity of RNase L antagonism was tested for L* from mouse (DA) and rat (RTV-1) TMEV strains as well as for VHEV. Coimmunoprecipitation and functional assay data confirmed the species specificity of L* activity and showed that L* from rat strain RTV-1 inhibited rat but not mouse or human RNase L. Next, we showed that the VHEV L* protein was phylogenetically related to L* of mouse viruses and that it failed to inhibit human RNase L but readily antagonized mouse RNase L, unambiguously showing the mouse origin of VHEV. IMPORTANCE Defining the natural host of a virus can be a thorny issue, especially when the virus was isolated only once or when the isolation story is complex. The species Theilovirus includes Theiler's murine encephalomyelitis virus (TMEV), infecting mice and rats, and Saffold virus (SAFV), infecting humans. One TMEV strain, Vilyuisk human encephalitis virus (VHEV), however, was isolated from mice that were inoculated with cerebrospinal fluid of a patient presenting with chronic encephalitis. It is therefore unclear whether VHEV was derived from the human sample or from the inoculated mouse. The L* protein encoded by TMEV inhibits RNase L, a cellular enzyme involved in innate immunity, in a species-specific manner. Using binding and functional assays, we show that this species specificity even allows discrimination between TMEV strains of mouse and of rat origins. The VHEV L* protein clearly inhibited mouse but not human RNase L, indicating that this virus originates from mice.


2005 ◽  
Vol 280 (50) ◽  
pp. 41694-41699 ◽  
Author(s):  
Masayuki Nakanishi ◽  
Nobutada Tanaka ◽  
Yasuaki Mizutani ◽  
Masahiko Mochizuki ◽  
Yoshihito Ueno ◽  
...  

2003 ◽  
Vol 13 (22) ◽  
pp. 3959-3961
Author(s):  
Yoshihito Ueno ◽  
Shusaku Okatani ◽  
Yuuki Yamada ◽  
Yukio Kitade
Keyword(s):  
Rnase L ◽  

2004 ◽  
Vol 14 (17) ◽  
pp. 4431-4434 ◽  
Author(s):  
Yoshihito Ueno ◽  
Shinji Ishihara ◽  
Yasutomo Ito ◽  
Yukio Kitade
Keyword(s):  
Rnase L ◽  

2004 ◽  
Vol 271 (13) ◽  
pp. 2737-2744 ◽  
Author(s):  
Masayuki Nakanishi ◽  
Akihiro Yoshimura ◽  
Norihisa Ishida ◽  
Yoshihito Ueno ◽  
Yukio Kitade
Keyword(s):  
Rnase L ◽  

1997 ◽  
Vol 186 (6) ◽  
pp. 967-972 ◽  
Author(s):  
JoAnn C. Castelli ◽  
Bret A. Hassel ◽  
Katherine A. Wood ◽  
Xiao-Ling Li ◽  
Kei Amemiya ◽  
...  

The 2–5A system contributes to the antiviral effect of interferons through the synthesis of 2–5A and its activation of the ribonuclease, RNase L. RNase L degrades viral and cellular RNA after activation by unique, 2′–5′ phosphodiester-linked, oligoadenylates [2–5A, (pp)p5′ A2′(P5′A2′)]n, n ⩾2. Because both the 2–5A system and apoptosis can serve as viral defense mechanisms and RNA degradation occurs during both processes, we investigated the potential role of RNase L in apoptosis. Overexpression of human RNase L by an inducible promoter in NIH3T3 fibroblasts decreased cell viability and triggered apoptosis. Activation of endogenous RNase L, specifically with 2–5A or with dsRNA, induced apoptosis. Inhibition of RNase L with a dominant negative mutant suppressed poly (I)·poly (C)–induced apoptosis in interferon-primed fibroblasts. Moreover, inhibition of RNase L suppressed apoptosis induced by poliovirus. Thus, increased RNase L levels induced apoptosis and inhibition of RNase L activity blocked viral-induced apoptosis. Apoptosis may be one of the antiviral mechanisms regulated by the 2–5A system.


Sign in / Sign up

Export Citation Format

Share Document